Jeff E. Knight, Chief Operating Officer at Crinetics Pharmaceuticals, Inc. (CRNX), sold 27,000 shares at $55.00 ($1.5M) on 2024-07-15, disclosed to the SEC on 2024-07-17.
Scheduled sale ($1.5M) by Chief Operating Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| Filing → |
| CRNX | SELL | 2025-03-21 | $477K | — | Filing → |
| CRNX | SELL | 2024-11-26 | $28K | — | Filing → |
| CRNX | SELL | 2024-06-28 | $42K | — | Filing → |